|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Anesthesiology, College of Physicians and Surgeons of Columbia University, New York, New York
Submitted 19 October 2005 ; accepted in final form 7 February 2006
Renal ischemia-reperfusion (IR) injury is a major clinical problem without effective therapy. We recently reported that volatile anesthetics protect against renal IR injury, in part, via their anti-inflammatory properties. In this study, we demonstrate the anti-inflammatory and antinecrotic effects of sevoflurane in cultured kidney proximal tubule cells and probed the mechanisms of sevoflurane-induced renal cellular protection. To mimic inflammation, human kidney proximal tubule (HK-2) cells were treated with tumor necrosis factor-
(TNF-
; 25 ng/ml) in the presence or absence of sevoflurane. In addition, we studied the effects of sevoflurane pretreatment on hydrogen peroxide (H2O2)-induced necrotic cell death in HK-2 or porcine proximal tubule (LLC-PK1) cells. We demonstrate that sevoflurane suppressed proinflammatory effects of TNF-
evidenced by attenuated upregulation of proinflammatory cytokine mRNA (TNF-
, MCP-1) and ICAM-1 protein and reduced nuclear translocation of the proinflammatory transcription factors NF-
B and AP-1. Sevoflurane reduced necrotic cell death induced with H2O2 in HK-2 cells as well as in LLC-PK1 cells. Sevoflurane treatment resulted in phosphorylation of prosurvival kinases, ERK and Akt, and increased de novo HSP-70 protein synthesis without affecting the synthesis of HSP-27 or HSP-32. We conclude that sevoflurane has direct anti-inflammatory and antinecrotic effects in vitro in a renal cell type particularly sensitive to injury following IR injury. These mechanisms may, in part, account for volatile anesthetics' protective effects against renal IR injury.
acute renal failure; HK-2 cells; inflammation; necrosis; perioperative period
This article has been cited by other articles:
![]() |
H. T. Lee, S. W. C. Chen, T. C. Doetschman, C. Deng, V. D. D'Agati, and M. Kim Sevoflurane protects against renal ischemia and reperfusion injury in mice via the transforming growth factor-{beta}1 pathway Am J Physiol Renal Physiol, July 1, 2008; 295(1): F128 - F136. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee, M. Kim, J. H. Song, S. W. C. Chen, G. Gubitosa, and C. W. Emala Sevoflurane-mediated TGF-{beta}1 signaling in renal proximal tubule cells Am J Physiol Renal Physiol, February 1, 2008; 294(2): F371 - F378. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kim, M. Kim, N. Kim, V. D. D'Agati, C. W. Emala Sr, and H. T. Lee Isoflurane mediates protection from renal ischemia-reperfusion injury via sphingosine kinase and sphingosine-1-phosphate-dependent pathways Am J Physiol Renal Physiol, December 1, 2007; 293(6): F1827 - F1835. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. T. Lee, M. Kim, M. Kim, N. Kim, F. T. Billings IV, V. D. D'Agati, and C. W. Emala Sr. Isoflurane protects against renal ischemia and reperfusion injury and modulates leukocyte infiltration in mice Am J Physiol Renal Physiol, September 1, 2007; 293(3): F713 - F722. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |